Results 31 to 40 of about 507,096 (126)

PHARMACOLOGICAL COST-BENEFIT ANALYSIS OF VACCINATION OF ADOLESCENTS BY CERVARIX [PDF]

open access: yes, 2011
Karcinom vrata maternice u svijetu je drugi po učestalosti u žena. U Hrvatskoj je na osmome mjestu zastupljenosti. Ova vrsta karcinoma je bolest mlađih žena.
Škrgatić, Lana   +13 more
core   +1 more source

Eco-effective fashion theory: how to implement the Cradle to Cradle® concept into fashion and clothing design?: the designer's professional, economic, social and enviromental role [PDF]

open access: yes, 2013
vaatetussuunnitteluun ja muotiin. Tutkimukseni pyrkii vastaamaan kahteen kysymykseen: 1. Kuinka soveltaa Cradle to Cradle® konsepti vaatesuunnitteluun ja muotiin? 2.
Kupsala, Heta
core   +2 more sources

Occupational HPV Exposure in Otolaryngology: A Scoping Review of Detection, Risk, and Prevention

open access: yesThe Laryngoscope, EarlyView.
This scoping review identified 10 studies evaluating occupational HPV exposure in otolaryngology. HPV DNA was detected in surgical plume following some HPV‐related procedures, including up to 56.7% of CO2 laser plume samples, while the only study assessing oral HPV among exposed clinicians reported a prevalence of 2.2%, not exceeding that of the ...
Ying Jie Li   +2 more
wiley   +1 more source

Human papillomavirus: Role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa

open access: yesInternational Journal of Infectious Diseases
Cervical cancer remains a leading cause of death among women in sub-Saharan Africa, accounting for nearly a quarter of global deaths from this disease. Its high incidence is due to the high prevalence of HIV, the persistence of human papillomavirus (HPV)
Christian Tague   +10 more
doaj   +1 more source

Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9

open access: yesHuman Vaccines & Immunotherapeutics, 2019
High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic vaccines available that protect against the majority of HPVs associated with cancer.
Nitesh K. Kunda   +6 more
doaj   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Relationship between HPV-specific vaccine antibodies in sera and genital samples.

open access: yes, 2013
(A) Neutralization titers were normalized to IgG levels in serum and genital samples for HPV16 (left panel; Cervarix® n = 21, Gardasil® n = 28) and HPV18 (right panel; Cervarix® n = 21, Gardasil® n = 26).
Rebecca Howell-Jones (408906)   +8 more
core   +1 more source

MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION

open access: yesБезопасность и риск фармакотерапии, 2018
Human papillomavirus refers to DNA-containing viruses and infects the skin and mucosal epithelium. One common way is to change the  expression of cellular genes by integrating the viral genome into  cellular DNA.
O. S. Alyautdina, M. A. Darmostukova
doaj   +1 more source

Knowledge Gaps and Awareness of Human Papillomavirus and Its Vaccine Among Educated Young Adults in Jordan: A Cross‐Sectional Study: A Cross‐Sectional Study

open access: yesPublic Health Nursing, EarlyView.
ABSTRACT Human papillomavirus (HPV) remains a major global public health concern and is strongly associated with cervical and several other cancers. In Jordan, the HPV vaccine has not yet been incorporated into the national immunization program, and public awareness appears limited.
Kareem M. Matalqa   +10 more
wiley   +1 more source

Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study. [PDF]

open access: yes, 2015
BACKGROUND: Spiromax® is a novel dry-powder inhaler containing formulations of budesonide plus formoterol (BF). The device is intended to provide dose equivalence with enhanced user-friendliness compared to BF Turbuhaler® in asthma and chronic ...
Philip Chetcuti   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy